Trademark: 79175768
Status Date
Friday, August 4, 2023
Registration Number
5126200
Registration Date
Tuesday, January 24, 2017
Filing Date
Monday, December 29, 2014
Published for Opposition
Tuesday, November 8, 2016
Cancellation Date
Friday, August 4, 2023
41 Entertainment television news programme services in the field of pharmaceutical products and sanitary preparations for medical purposes broadcast over the internet; organizing community festivals featuring primarily pharmaceutical exhibition for medical purposes; arranging professional workshop and training courses in the field of pharmaceutical products and medicine for medical purposes; training services in the field of pharmaceutical and sanitary preparations for medical purposes; education service, namely, providing tutoring in the field of pharmaceutical and sanitary preparations for medical purposes; providing information relating to organizing community cultural activities and contests
5 Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceuticals; gelatin capsules sold empty for pharmaceuticals; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases also rare; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation also rare; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for treating diabetes also rare; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; sanitary preparations for medical purposes; all-purpose disinfectants
42 Conducting early evaluations in the field of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology, treatment of cancer, diabetes, analgesic preparations, nerve grow factors, oncology, organ transplantation, antibiotics, respiratory diseases, bone diseases, rare diseases; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, medical diagnostics, drug development and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer, diabetes, respiratory diseases, bone diseases, rare diseases, ocular disorders and diseases; research and development in the pharmaceutical and biotechnology fields
The mark consists of a hexagon with a letter "D" in the center and the wording "DOMPÉ" to the right of the design.
DOMPÉ DOMPÉ
Color is not claimed as a feature of the mark.
Nov 12, 2015
Assigned To Examiner
Nov 7, 2015
Sn Assigned For Sect 66a Appl From Ib
Nov 10, 2015
Limitation From Original Application Entered
Nov 12, 2015
New Application Office Supplied Data Entered
Jun 1, 2016
Correspondence Received In Law Office
Nov 17, 2015
Application Filing Receipt Mailed
Nov 19, 2015
Assigned To Examiner
Nov 25, 2015
Non-Final Action Written
Nov 26, 2015
Non-Final Action (Ib Refusal) Prepared For Review
Dec 1, 2015
Refusal Processed By Mpu
Dec 1, 2015
Non-Final Action Mailed - Refusal Sent To Ib
Dec 18, 2015
Refusal Processed By Ib
Apr 28, 2016
New Representative At Ib Received
Jun 1, 2016
Teas Response To Office Action Received
Sep 28, 2016
Teas Request For Reconsideration Received
Oct 19, 2016
Notification Of Notice Of Publication E-Mailed
Oct 19, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 19, 2016
Notification Of Possible Opposition Sent To Ib
Jun 2, 2016
Teas/Email Correspondence Entered
Jun 30, 2016
Final Refusal Written
Jun 30, 2016
Final Refusal E-Mailed
Jun 30, 2016
Notification Of Final Refusal Emailed
Sep 28, 2016
Correspondence Received In Law Office
Sep 28, 2016
Teas/Email Correspondence Entered
Sep 28, 2016
Approved For Pub - Principal Register
Nov 8, 2016
Published For Opposition
Nov 8, 2016
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2017
Registered-Principal Register
Apr 24, 2017
Final Disposition Notice Created, To Be Sent To Ib
Feb 12, 2021
New Representative At Ib Received
Nov 18, 2016
Notification Of Possible Opposition - Processed By Ib
Apr 26, 2017
Final Disposition Processed
Apr 26, 2017
Final Disposition Notice Sent To Ib
May 20, 2017
Final Decision Transaction Processed By Ib
Jun 4, 2021
Change Of Name/Address Rec'd From Ib
Jan 24, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Aug 4, 2023
Cancelled Section 71
Apr 4, 2024
Total Invalidation Of Reg Ext Protection Created
Apr 13, 2024
Invalidation Processed
Apr 13, 2024
Total Invalidation Of Reg Ext Protection Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
